Get started
Author

Carol Delaney

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
2010 · Paul G. Richardson, Edie Weller, et al. · Blood · 862
Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma
2009 · Paul G. Richardson, Edie Weller, et al. · Journal of Clinical Oncology · 162
Lenalidomide Plus Bortezomib (Rev-Vel) in Relapsed and/or Refractory Multiple Myeloma (MM): Final Results of a Multicenter Phase 1 Trial.
2006 · Paul G. Richardson, S. Jagannath, et al. · Blood · 69
Lenalidomide, Bortezomib, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma: Encouraging Efficacy in High Risk Groups with Updated Results of a Phase I/II Study
2008 · Paul Richardson, Sagar Lonial, et al. · Blood · 66
Lenalidomide, Bortezomib, and Dexamethasone (Rev/Vel/Dex) as Front-Line Therapy for Patients with Multiple Myeloma (MM): Preliminary Results of a Phase 1/2 Study.
2007 · Paul Richardson, Sundar Jagannath, et al. · Blood · 30
Clinical Trial Evaluating DC/AML Fusion Cell Vaccination In AML Patients
2013 · Jacalyn Rosenblatt, Richard M. Stone, et al. · Blood · 8
High Response Rates and Encouraging Time-to-Event Data with Lenalidomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Final Results of a Phase I/II Study.
2009 · Paul G Richardson, Sagar Lonial, et al. · Blood · 8
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
2013 · Jacalyn Rosenblatt, Irit Avivi, et al. · Transplantation and Cellular Therapy · 7
Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation
2012 · Jacalyn Rosenblatt, Irit Avivi, et al. · Blood · 7
A224 Lenalidomide, Bortezomib, and Dexamethasone Has Notable Activity in High-Risk First-Line Myeloma
2009 · PG Richardson, S Lonial, et al. · Clinical Lymphoma & Myeloma · 4
Clinical Trial Evaluating DC/AML Fusion Cell Vaccination in AML Patients Who Achieve a Chemotherapy-Induced Remission
2014 · Jacalyn Rosenblatt, Richard M. Stone, et al. · Transplantation and Cellular Therapy · 3
Clinical Trial Evaluating DC/AML Fusion Cell Vaccination Alone and in Conjunction with PD-1 Blockade in AML Patients Who Achieve a Chemotherapy-Induced Remission
2011 · Jacalyn Rosenblatt, Richard M. Stone, et al. · Blood · 3
Clinical Trial Evaluating DC/AML Fusion Cell Vaccination Alone and in Conjunction with PD-1 Blockade in AML Patients Who Achieve a Chemotherapy-Induced Remission
2012 · J. Rosenblatt, R. Stone, et al. · Transplantation and Cellular Therapy · 2
PDF
Immune Reconstitution Following Reduced Intensity Conditioning With CAMPATH-1H Versus Total Lymphoid Irradiation/Anti-Thymocyte Globulin Prior To Allogeneic Stem Cell Transplantation
2010 · B. Glotzbecker, H. Mills, et al. · Transplantation and Cellular Therapy · 1
PDF
A Comparative Analysis of Immune Reconstitution Following Reduced Intensity Conditioning with CAMPATH-1H and Total Lymphoid Irradiation/Anti-Thymocyte Globulin Prior to Allogeneic Stem Cell Transplantation.
2009 · Brett Glotzbecker, Heidi Mills, et al. · Blood · 1
Addition of Clofarabine to TLI/ATG Conditioning: Impact on Immune Reconstitution and Clinical Outcomes
2012 · B. Glotzbecker, H. Mills, et al. · Transplantation and Cellular Therapy
PDF
Addition of Clofarabine to TLI/ATG Conditioning: Impact on Immune Reconstitution and Clinical Outcomes,
2011 · Brett Glotzbecker, Heidi Mills, et al. · Blood
Works count: 17
Citation count: 1,233
H-index: 7
I10-index: 5
Year
Topic
Type